• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Systems serology-based comparison of humoral immune responses induced by liposome or aluminum hydroxide adjuvanted SARS-CoV-2 spike prote

tetano

Editor, Senior Moderator
Sci Rep


. 2025 May 28;15(1):18734.
doi: 10.1038/s41598-025-01902-6. Systems serology-based comparison of humoral immune responses induced by liposome or aluminum hydroxide adjuvanted SARS-CoV-2 spike protein

Soo Ji Kim[SUP] 1 2 [/SUP], Taewoo Kim[SUP] 1 [/SUP], Satyanarayana Bejjani[SUP] 1 [/SUP], Mi Sun Kim[SUP] 1 [/SUP], Jung Hyuk Lee[SUP] 1 [/SUP], Yuna Shin[SUP] 1 [/SUP], Sun-Je Woo[SUP] 1 [/SUP], Beom Min Cheon[SUP] 1 [/SUP], Doyoung Kim[SUP] 1 2 [/SUP], Sumin Lee[SUP] 1 [/SUP], Eunjin Cho[SUP] 1 [/SUP], Junhyeon Lee[SUP] 1 [/SUP], Ruchirkumar Pansuriya[SUP] 1 [/SUP], Wook-Jin Park[SUP] 3 [/SUP], Gaurav Pandey[SUP] 1 [/SUP], Ravi Ganapathy[SUP] 1 [/SUP], Jung-Ah Choi[SUP] 1 [/SUP], Ju Yeon Park[SUP] 1 [/SUP], Deok Ryun Kim[SUP] 1 [/SUP], Cheol-Heui Yun[SUP] 2 [/SUP], Jae Seung Yang[SUP] 4 [/SUP], Byoung-Shik Shim[SUP] 5 [/SUP], Manki Song[SUP] 6 [/SUP]



Affiliations
Free article Abstract

Adjuvants play a crucial role in enhancing vaccine-induced immune responses by shaping the magnitude and quality of humoral and cellular immunity. However, the mechanism through which different adjuvants modulate effector functions is not fully understood. Here, we developed an International Vaccine Institute liposome-based adjuvant (ILA) and comprehensively compared humoral immune profiles in mice following the administration of SARS-CoV-2 spike (S) protein formulated with either ILA or aluminum hydroxide (alum) using a systems serology approach. No significant differences were observed in antigen-specific total IgG and neutralizing antibody titers between the two adjuvanted groups. However, the ILA group demonstrated a broader spectrum of humoral immune responses, exhibiting higher levels of antigen-specific IgG2a, IgG2b, and IgG3 compared to the alum group. In addition, S-specific antibody binding to Fcγ receptor (FcγR) 1 and FcγR4 was significantly higher in the ILA group compared to alum. Moreover, Fc-mediated effector functions, such as antibody-mediated monocyte and neutrophil phagocytosis, were significantly more active in the ILA-adjuvanted group. Overall, these findings demonstrate that ILA induces antibodies with superior FcγR binding and Fc-mediated effector functions compared to alum, highlighting its potential role in improving vaccine-induced immunity.

Keywords: Adjuvant; Aluminum hydroxide; Liposome; SARS-CoV-2; Systems serology.

 
Back
Top Bottom